In the RA-1000, a random-access discrete analyzer, an inert fluorocarbon fluid is used to prevent interaction and carryover. Production-model instruments were evaluated in two laboratories with respect to determination of glucose, creatinine, total protein, inorganic phosphorus, cholesterol, alkaline phosphatase, lactate dehydrogenase, creatine kinase, yglutamyltransferase, and aspartate and alanine aminotransferases. Within-run, among-run, and day-to-day (for 15 days) precision was assessed, and results were correlated with those obtained by the methods routinely in use in our departments. Precision was excellent, correlation acceptable. In operation, the sample-and reagent-probes are initially positioned over their respective trays with the syringes in the discharged position but with the reagent lines ifiled with the fluorocarbon. A small air bubble is aspirated into each probe, and the probes are then lowered into the sample cup and reagent container. Sample and reagent are aspirated into the tubing by the syringe pumps. The computer controls aspiration of a specified volume of sample (2.5-30 pL) and reagent (325-375 pL) through the syringes and into the tubing. The probes are then raised, moved horizontally, and positioned over the reaction cell cuvette, on the reaction tray. The probes are lowered into this cuvette, and sample and reagent are discharged by the syringe pumps. A small amount of the fluorocarbon is also introduced into the cuvette by a peristaltic pump. a relative (to water) density of 1.9, it settles to the bottom of the cuvette. The analytical reaction that takes place in the cuvette can be monitored by colorimetric or ultraviolet detection, with the use of direct end-point or initial or kinetic rate reactions. The probes are raised and moved horizontally while the reagent and sample trays rotate to a position appropriate for the next analysis.
In the RA-1000, a random-access discrete analyzer, an inert fluorocarbon fluid is used to prevent interaction and carryover. Production-model instruments were evaluated in two laboratories with respect to determination of glucose, creatinine, total protein, inorganic phosphorus, cholesterol, alkaline phosphatase, lactate dehydrogenase, creatine kinase, yglutamyltransferase, and aspartate and alanine aminotransferases. Within-run, among-run, and day-to-day (for 15 days) precision was assessed, and results were correlated with those obtained by the methods routinely in use in our departments. Precision was excellent, correlation acceptable. an inert, deformable surface that prevents carryover and ensures accurate delivery. In operation, the adjacent aqueous liquids have contact only with the fluorocarbon and not with the solid surface of the tubing or other fittings on the instrument.
The instrument consists of sample probes and reagent probes, which operate through Hamilton-type syringes; a circular 30-position sample tray; a reagent tray (maximum of 14 reagent containers); a 100-position reaction tray; and a computer, which controls the operation.
In operation, the sample-and reagent-probes are initially positioned over their respective trays with the syringes in the discharged position but with the reagent lines ifiled with the fluorocarbon. A small air bubble is aspirated into each probe, and the probes are then lowered into the sample cup and reagent container. Sample and reagent are aspirated into the tubing by the syringe pumps. The computer controls aspiration of a specified volume of sample (2.5-30 pL) and reagent (325-375 pL) through the syringes and into the tubing. The probes are then raised, moved horizontally, and positioned over the reaction cell cuvette, on the reaction tray. The probes are lowered into this cuvette, and sample and reagent are discharged by the syringe pumps. A small amount of the fluorocarbon is also introduced into the cuvette by a peristaltic pump. a relative (to water) density of 1.9, it settles to the bottom of the cuvette. The analytical reaction that takes place in the cuvette can be monitored by colorimetric or ultraviolet detection, with the use of direct end-point or initial or kinetic rate reactions. The probes are raised and moved horizontally while the reagent and sample trays rotate to a position appropriate for the next analysis.
Back-and-forth and stop/start rotation of the reaction tray mixes the samples with the reagents. With the RA-1000, random access analysis is possible at an analytical rate of 240 assays per hour. The operator's role is merely to place samples in the cups, ensure that reagent containers are in place, and then request analysis, identifying the specimen through the computer keyboard. Calibration, test-result analysis, detection of machine problems, and calculation of results are all done by the computer.
Our evaluation of this instrument, reported here, included studies of the precision of the methods, linearity of the procedures, and correlation of the values generated by the RA-1000 with those obtained in our respective clinical laboratories by our routinely used methods.
Materials and Methods
The production-model HA-bOO and reagents we used in these studies were provided by the manufacturer.
The tests we evaluated included alkaline phosphatase (EC 3. 15 days, in which all of the reference materials were assayed in duplicate.
Thus at each clinical laboratory there were eight different controls x two aliquots per experiment x two experiments per day x 15 days, for a total of 480 observations per method. The aim was to have analytes at three concentrations that would span the linear range of the method, and to evaluate both total precision and its day-today, among-run, and within-run components.
In the correlation studies, we were guided by a proposed NCCLS standard (13).
Results
Precision. Table 1 summarizes within-run and total precision for replicate samples in each category. All coefficients of variation were acceptable, and the mean values obtained with the two instruments did not differ significantly. The highest CVs in the within-run experiments were seen at low activities of enzymes. In several instances, a large variation was observed for high values of creatine kinase activity, for "in-house" quality-control specimens prepared from lyophilized material early in the work day and allowed to stand in the refrigerator until the afternoon precision experiment, a practice not ordinarily followed. In many instances, the CVs in the total-precision studies were higher. However, for most constituents, the CVs were <2.5%. We conclude that the precision of this instrument equals or exceeds the multichannel variability, medically significant required precision, or intralaboratory variability reported in surveys of referee or university hospitals (Table 2) . results obtained for the same specimen with the RA-1000 and by the routine procedures mentioned above. We emphasize that all the routine comparison enzyme measurements at one institution2 were done at 30#{176}C, whereas all RA-1000 assays were carried out at 37 #{176}C. This difference in assay temperature results in a wide difference in slope, but the correlation coefficients (r) were excellent.
Correlation.
As part of the evaluation, all of the correlation assays were done in duplicate, by both the RA-1000 and the comparative methods. of the differences between duplicates measured in the RA-1000 and in each of the correlation instruments. As can be seen, the precision of duplicates for all assays in the correlation study, regardless of the instrument, was very good.
Discussion
In the RA-1000 the use of an inert fluorocarbon has eliminated most of the problems of carryover and cross reaction that exist in continuous-flow instruments ( The small sample and reagent requirements plus the random access capability make the instrument particularly useful as a "back-up" for (e.g.) SMAC , particularly in the case of enzyme assays that require dilution, in emergency laboratories, and in laboratories where the demand is relatively small and large batch-type instruments are not suitable. These advantages can only be acceptable if the precision and accuracy of the RA-1000 are at least equivalent to those available with established systems.
From our evaluation of production-quality RA-l000s in our two laboratories, we conclude that total precision is as good as that obtained with the comparison instruments. It is much better than is required as medically significant, and the intralaboratory precision is better than reported hitherto. The degree of correlation with the methods used routinely in our respective laboratories indicates that the RA-1000 will provide values for these analytes that compare favorably with the routine values. Additional studies are now underway, intended to establish the flexibility of the RA-1000 and its potential with respect to user-introduced methods.
The RA-1000 is easy to operate. It was well received by the technologists and re-calibration is required relatively seldom. The instrument at one institution1 did not require calibration during six months of daily use; at the other,2 the instrument was calibrated arbitrarily once each week. Such stability of performance offers the laboratory a great savings in calibration material. One RA-1000' had no "down-time" during the evaluation; it was in operation each day. The other2 required one or two minor adjustments but gave very satisfactory performance.
